Srilanka, Aug. 6 -- Hemas delivered revenue growth of 0.9% YoY to Rs. 28.77 Bn in Q1 FY27, supported by growth in Consumer Brands, Hospitals and Mobility. Gross profit margin improved to 30.4%, demonstrating the benefits of pricing actions and portfolio mix improvements.
The escalation of conflict in the Middle East led to rising global fuel, freight and raw material costs. At the same time, the Sri Lankan Rupee weakened and inflation increased, driving up operating expenses across many of our businesses. Profitability was impacted by this sharp rise in costs, resulting in EBITDA declining 14.1% to Rs. 2.3 Bn and Group earnings declining 21.4% to Rs. 937 Mn.
GROUP AT A GLANCE
Going forward, segmental reporting will be broken down into C...